2007, FDA, Fraud and Governance - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

FDA

Fraud

Governance

An Abuse of Discretion So Vast…. Our Long-Delayed Critique of the Valsartan MDL Class Action Certifications

Drug & Device Law

NOVEMBER 10, 2023

These class certifications combined 428 different pharmaceutical products, produced and marketed by 28 separate defendants, with claims governed by the laws of 52 separate jurisdictions. FDA, “ Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications ” (Aug. Valsartan , 2023 WL 1818922, at *24.

FDA

FDA Governance Fraud

Suing the Certifiers – A Dangerous Undertaking

Drug & Device Law

AUGUST 8, 2022

The unfortunate truth is that ECFMG was also a victim of this fake doctor’s fraud. Furthermore, trade associations often serve to assist the government in areas that it does not regulate. Both state and federal governments allegedly relied on the defendant “accreditation process to help evaluate HCOs.” at 183 (quoting Meyers v.

Doctors

Doctors Fraud Licensing Compliance

An Abuse of Discretion So Vast…. Our Long-Delayed Critique of the Valsartan MDL Class Action Certifications

Suing the Certifiers – A Dangerous Undertaking

Stay Connected